Uta Meyding-Lamade

5 Excellent • 2 avis
35 années d'expérience
Lieu : Allemagne, Francfort-sur-le-Main
Clinique :
4.5
Nordwest Clinic (Krankenhaus)
La Professeure Uta Meyding-Lamade dirige le Département de neurologie de la Clinique Nordwest. Elle est spécialisée dans la sclérose en plaques et les troubles neurologiques.
- Dirige le groupe Encéphalite Virale de la Société Allemande de Neurologie
- Conseillère régionale pour le traitement des AVC à l'Institut Robert Koch
- Récipiendaire du prix de la Fondation Braun pour les traitements innovants
- Formation à l'Université de Heidelberg, à l'University College London et à l'Université de Memphis
Lire la suite

5 Excellent

2 avis

Prix du forfait à partir de$7,230.51

Bookimed Insights : Meilleurs spécialistes d'ocrevus (ocrélizumab) en Allemagne (2026)

Bookimed a coordonné 9 demandes pour Ocrevus (ocrélizumab) en Allemagne, en collaboration avec 1 spécialistes. Les médecins de ce tableau se distinguent régulièrement par leurs qualifications et leur expertise à répondre aux besoins spécifiques des patients. Toutes les informations proviennent de cas réels de patients et d'offres de traitement créées par nos cliniques partenaires.

Classement	Médecin	expérience	Bon choix pour	Ce qui les distingue	Clinique et emplacement	Consultation
#1	Uta Meyding-Lamade	35 années d'expérience	Sclérose en plaques sous traitement par Ocrevus	Une voix qui fait autorité en neurologie, assumant des rôles de leadership au sein de la Société allemande de neurologie et de l'encadrement du traitement des AVC. Reconnu pour ses approches thérapeutiques innovantes.	Nordwest Clinic (Krankenhaus) Allemagne	de $375

FAQ

Ces FAQ sont basées sur les questions de patients réels cherchant des soins médicaux avec Bookimed. Les réponses sont fournies par des experts médicaux et des représentants de cliniques réputées.

Is Ocrevus (ocrelizumab) approved and reimbursed for multiple sclerosis in Germany?

Ocrevus is approved and reimbursed in Germany for relapsing forms and early primary progressive multiple sclerosis. Authorized by the European Commission, it is typically covered by statutory and private health insurance. Patients usually only pay a small flat copayment for this disease-modifying therapy.

Approval status: European Medicines Agency approved Ocrevus for adult patients in Germany in 2018.
Insurance coverage: Statutory and private insurers typically reimburse costs after a neurologist's assessment.
Patient copayment: State insurance patients generally pay a small fee capped at 10 euros.
Medical oversight: Neurologists at Focus-ranked centers like Nordwest Clinic oversee long-term treatment plans.

Bookimed Expert Insight: While statutory insurance covers treatment, approval often requires proving prior therapy failures or specific disease progression. Our data shows specialized centers like Nordwest Clinic in Frankfurt manage these complex reimbursement applications. This clinical support can reduce waiting times, which otherwise extend up to 1 year.

Patient Consensus: Initial insurance denials are common, but appeals supported by MRI evidence usually succeed within months. Private insurance holders often start treatment significantly faster than those using the state system.

Which German hospitals or doctors are experienced with Ocrevus infusions?

Germany hosts elite-level expertise for Ocrevus (ocrelizumab) infusions within university-affiliated neurology centers and specialized Multiple Sclerosis (MS) clinics. Institutions like Nordwest Clinic (Krankenhaus) in Frankfurt, Charité Berlin, and Asklepios Klinik Barmbek follow strict German Neurology Society protocols for infusion safety.

Top specialists: Prof. Uta Meyding-Lamade at Nordwest Clinic leads nationwide autoimmune neurology initiatives.
Leading institutions: Charité Berlin and University Hospital Heidelberg house dedicated neuroimmunology research centers.
Quality standards: Facilities like Nordwest Clinic maintain Focus magazine rankings and TÜV technical certifications.
Clinical research: University Hospital Dresden actively studies the long-term effectiveness of ocrelizumab infusions.

Bookimed Expert Insight: Focus on clinics with high patient volumes, such as Nordwest Clinic, which treats 61,000 patients annually. Large-scale centers often have more streamlined pre-medication protocols. This can significantly reduce the risk of common infusion-related reactions compared to smaller facilities.

Patient Consensus: Patients emphasize preparing for 4–6 hour sessions and requesting allergy-tested pre-meds early. While university hospitals are praised for medical precision, wait times can vary significantly by region.

How is the medicine given and how long does each treatment take?

Doctors in Germany administer Ocrevus via intravenous infusion within specialized day-case hospital centers. The procedure follows a maintenance schedule every 6 months. Initial loading doses take approximately 2.5 hours. Subsequent maintenance sessions typically last between 1.5 to 4 hours depending on patient tolerance.

Administration route: Medical staff deliver Ocrevus through a slow intravenous drip into a vein.
Infusion cycles: Patients receive two 300 mg loading doses followed by 600 mg maintenance infusions.
Pre-medication protocol: Clinicians provide corticosteroids and antihistamines 30 minutes before starting to prevent reactions.
Observation period: Patients remain under clinical supervision for 1 hour after the infusion finishes.

Bookimed Expert Insight: German neurology centers like Nordwest Clinic often rank in Focus Top 10 lists for MS care. This specialization ensures they manage infusion rates more precisely than general practices. This targeted approach frequently reduces the standard 4-hour session to a faster 2-hour maintenance cycle.

Patient Consensus: Many patients recommend bringing a tablet or book. The total clinic time often reaches 6 hours during the first loading phase due to pharmacy prep and monitoring.

What pre-tests and monitoring are required before starting Ocrevus in Germany?

Before starting Ocrevus in Germany, patients undergo mandatory screenings for hepatitis B, tuberculosis, and JC virus status. Clinical protocols also require baseline blood panels, liver function checks, and immunoglobulin testing. Specialized centers like Nordwest Clinic follow German Multiple Sclerosis Therapy Consensus Group guidelines to ensure safety.

Infection screening: Mandatory hepatitis B (HBsAg, anti-HBc) and tuberculosis tests before the first dose.
Blood panels: Baseline complete blood count (CBC) and quantitative serum immunoglobulin (IgG/IgM) levels.
Liver health: Assessment of liver enzymes (ALT/AST) and bilirubin levels before starting therapy.
Vaccination review: Live-attenuated vaccines must be completed at least 4 to 6 weeks before.

Bookimed Expert Insight: Leading German neurologists like Prof. Uta Meyding-Lamade at Nordwest Clinic prioritize JC virus (JCV) antibody testing before initiation. While not always mandated globally, German clinics often use JCV status as a primary safety signal. This proactive approach helps doctors tailor long-term monitoring for potential neurological complications.

Patient Consensus: Patients emphasize requesting hepatitis B and JCV results 6 weeks early to prevent scheduling delays. Keeping a personal lab diary helps track baseline immunity levels during the 6-month infusion cycles.

What are the main safety risks and contraindications?

Ocrevus treatment requires screening for active hepatitis B and untreated latent tuberculosis, which are absolute contraindications. Primary safety risks include infusion-related reactions, serious respiratory infections, and shingles. German-standard protocols mandate baseline screenings and specific vaccination timelines to ensure patient safety and drug efficacy.

Absolute contraindications: Active hepatitis B infection, untreated latent tuberculosis, or history of severe allergic reactions.
Infusion reactions: Occur in 40–50% of first doses, requiring antihistamine and steroid premedication strategies.
Infection risks: B-cell depletion increases susceptibility to shingles, respiratory tract infections, and rare neurological conditions.
Vaccination protocol: Patients must complete all required immunizations 4 to 6 weeks before starting therapy.

Bookimed Expert Insight: German clinics like Nordwest Clinic utilize Focus-ranked neurology departments to manage complex screenings. Data shows German protocols often include mandatory IGRA testing for tuberculosis before approval. This rigorous screening process ensures high safety standards for patients receiving immunosuppressive therapies in Frankfurt.

Patient Consensus: Many emphasize the importance of tracking skin changes and scheduling annual cancer screenings. Patients often suggest discussing IgG levels yearly with doctors to prevent recurring respiratory infections.

How often will I need to travel to Germany if I start Ocrevus there?

Standard Ocrevus treatment in Germany requires 3 initial trips during the first year, followed by semi-annual maintenance visits. The first month involves 2 separate loading doses spaced 14 days apart. After 6 months, you return for maintenance infusions every 6 months.

Initial loading phase: You must travel for 2 doses administered 2 weeks apart.
Maintenance schedule: After the loading phase, 1 infusion is required every 6 months.
Treatment duration: Standard intravenous infusions typically last between 2 to 4 hours.
Subcutaneous option: Some clinics offer 10-minute administrations using the newer Ocrevus Zunovo version.
Medical visa: Non-EU citizens often utilize a 90-day Schengen Visa (Type C) for travel.

Bookimed Expert Insight: Nordwest Clinic in Frankfurt is a top choice because they specialize in managing international MS patients. Prof. Uta Meyding-Lamade, who leads their Neurology Department, has extensive experience in neuro-immunology. Choosing a major hub like Frankfurt simplifies travel since the clinic is close to a primary international airport.

Patient Consensus: Many patients coordinate local blood work at home between visits to minimize travel. Some mention the `crap gap` where symptoms return slightly before the next scheduled dose.

Do I need special vaccinations before therapy in Germany?

Patients receiving Ocrevus (ocrelizumab) in Germany must complete vaccinations 2 to 4 weeks before starting therapy. Immunosuppressants significantly reduce your immune response to vaccines. German neurologists require updating live vaccines like measles and mumps prior to the first infusion to ensure long-term safety.

Pre-treatment timeline: Complete all required immunizations at least 14 days before your first infusion.
Live vaccine restriction: Administer MMR or varicella vaccines beforehand as they are prohibited during treatment.
Routine boosters: Prioritize pneumococcal, seasonal flu, and COVID-19 shots to maximize antibody production.
Legal requirements: Proof of measles immunity is mandatory for treatment in German healthcare facilities.

Bookimed Expert Insight: German clinics like Nordwest Clinic utilize a rigorous pre-treatment checklist for MS therapies. Our data shows top specialists like Prof. Uta Meyding-Lamade coordinate closely with the Robert Koch Institute guidelines. This proactive screening ensures patients avoid treatment delays often caused by missing documentation. Always bring your international vaccination record (Impfpass) to your first consultation to streamline this process.

Patient Consensus: Patients frequently highlight that German neurologists are very strict about the 4-week vaccination window. Many recommend asking for the specific MS vaccination checklist immediately after your initial diagnosis to avoid scheduling setbacks.

Les meilleurs doctors à Francfort-sur-le-Main pour votre Ocrevus (ocrélizumab) - TOP 1 des médecins

Obtenez des devis de 3 meilleurs spécialistes Ocrevus (ocrélizumab) en Allemagne

Choisissez le pays avec les meilleurs prix pour les services médicaux